RJY aims to become the cleanest city in the State
Rajamahendravaram: Municipal Corporation Commissioner Ketan Garg said that efforts are underway to transform Rajamahendravaram into the cleanest city in the state. Speaking at the 'Beat the Heat' event under the 'Swachh Andhra–Swarnandhra' initiative at VAMBAY Housing Complex in Aava area of 16th Ward on Saturday, he urged citizens to consider the responsibility of planting and nurturing trees as their own.
The event was attended by Joint collector S Chinna Rammudu, MLC Somu Veerraju, and others. Commissioner Garg said that the Swachh Andhra–Swarnandhra programmes are being effectively implemented across the city. He stated that the primary objective of the 'Beat the Heat' campaign is to create awareness among the public about precautionary measures to protect themselves from the scorching summer heat.
Garg further informed that 40 water kiosks have been set up across the city, and nets have been installed at various traffic signals to protect commuters from direct sunlight. Additionally, a total of 6,560 rainwater harvesting structures have been established, covering the city and 10 surrounding panchayats.
The Commissioner announced that Rs 25 lakh has been sanctioned for the construction of a compound wall around the Urban Health Centre's vacant land, and a bio-fencing with plants will be established soon. He also encouraged every citizen to plant at least one tree and take responsibility for its growth. Joint collector S Chinna Rammudu advised people to take necessary precautions to protect their health during the rising temperatures, especially children and the elderly. He recommended staying indoors unless necessary and consuming plenty of fluids, including ORS. He also suggested arranging water bowls for animals and birds.
MLC Somu Veerraju lauded the city's improved performance in the Swachh Andhra– Swarnandhra grading and called for a ban on plastic usage to protect the environment.
Additional Commissioner PV Ramalingeswar, Secretary G Shailajavalli, Superintending Engineer MCH Koteshwar Rao, and MHO Vinuthna also participated in the event.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Standard
36 minutes ago
- Business Standard
Suven Life Sciences Ltd Slides 3.06%, BSE Healthcare index Shed 1.34%
Suven Life Sciences Ltd has added 6% over last one month compared to 0.02% fall in BSE Healthcare index and 0.02% drop in the SENSEX Suven Life Sciences Ltd fell 3.06% today to trade at Rs 220. The BSE Healthcare index is down 1.34% to quote at 42505.21. The index is down 0.02 % over last one month. Among the other constituents of the index, Syncom Formulations (India) Ltd decreased 2.97% and Concord Biotech Ltd lost 2.72% on the day. The BSE Healthcare index went up 15.59 % over last one year compared to the 5.82% surge in benchmark SENSEX. Suven Life Sciences Ltd has added 6% over last one month compared to 0.02% fall in BSE Healthcare index and 0.02% drop in the SENSEX. On the BSE, 155 shares were traded in the counter so far compared with average daily volumes of 1.08 lakh shares in the past one month. The stock hit a record high of Rs 272 on 12 Jun 2025. The stock hit a 52-week low of Rs 97.03 on 20 Jun 2024.
New Indian Express
4 hours ago
- New Indian Express
Super speciality GH for kids to come up in Guindy
CHENNAI: The state government has identified 6.5 acres of land at the King Institute of Preventive Medicine and Research in Guindy for setting up a super speciality hospital exclusively meant for children. The construction will begin in September and the work will be completed in two years, health minister Ma Subramanian said. Subramanian along with health secretary P Senthilkumar and Dr MGR Medical University vice-chancellor Dr K Narayanasamy inspected the site on Sunday. Speaking to reporters, Subramanian said the project will cost Rs 487.7 crore. The hospital will have a six-storey building and will include quarters for nurses, doctors, and professors, among other facilities. It will have 20 specialities and 750 beds, including 100 for ICU, he added. Apart from paediatric super speciality departments including medicine, critical care, surgery, and gastroenterology, it will also have higher paediatric super speciality departments including oncology, urology, neurosurgery, and transplant unit, the minister said. It will be constructed with biochemistry, microbiology, pathology and imaging suite diagnostic labs apart from dialysis unit, endoscopy suite, interventional radiology and other facilities. An announcement regarding an exclusive super speciality hospital for children had been made in the Assembly earlier.
New Indian Express
15 hours ago
- New Indian Express
‘We plan to add 1,700 beds by FY27; 57% beds likely in tier 2/3 cities'
Kochi- and Dubai-based Aster DM Healthcare, founded by Dr Azad Moopen in 1987 with a single clinic in Dubai, expects to complete the takeover of the Blackstone and TPG-backed Quality Care Hospital by the fourth quarter of this fiscal. The takeover will result in the third largest hospital chain Aster Quality Care, after Apollo and Fortis, with 38 hospitals across four brands -- Aster DM, Care Hospitals, KIMS Health and Evercare -- offering over 10,150 beds spread across 27 locations. Aster Quality Care is now jointly controlled by the Moopen family holding 24% and Blackstone owning 30.7%. In an interaction with Benn Kochuveedan of TNIE, Dr Azad Moopen shares his plans and expectations from the largest deal that his group has done. Excerpts: When do you see the merger of Quality Care Hospital getting completed? What are the targets in terms of revenue, profit expansion etc? The merger brings together four leading healthcare brands — Aster DM, Care Hospitals, KIMS Health, and Evercare — forming one of the largest hospital chains with 38 hospitals and over 10,150 beds across 27 cities. Financially, the merger strengthens the balance sheet and cash flow, enabling accelerated expansion plans. We aim to increase bed capacity to around 13,300 beds by FY27, further expanding our reach into tier 2 and 3 cities, providing a platform for sustained growth in the future. The merger is expected to be concluded by Q4FY26, with benefits expected to start flowing in from early FY27. What are the synergies you see from the merger? The merger unlocks significant synergies that will drive growth, operational efficiencies, and enhanced patient care across the combined network. Integrating our extensive hospital portfolios will allow the new entity to benefit from economies of scale by negotiating better terms with suppliers, reducing costs, and streamlining inventory management that will lower operational expenses and improve margins. What is the capex plan for fiscal 2026, especially in light of the merger-driven expansion? How many more hospitals and beds to come up this fiscal? We plan to add 1,700 beds by FY27, taking the total bed tally in India to over 6,800 through the organic route and will further look for expansion through the inorganic route. Our overall capital allocation for expansion across the domestic market is Rs 1,400 crore, of which we have already spent around Rs 350-400 crore. You have announced a Rs 850-crore investment in Kerala. What is the strategic thinking behind focusing so much on Kerala, which is often seen as a relatively mature market? Kerala is now poised for a significant transformation with a planned investment of Rs 850 crore over the next three years. This expansion will be anchored by two major greenfield projects: Aster Capital Trivandrum, a 454-bed tertiary care facility, and Aster MIMS Kasaragod, a 264-bed multispecialty hospital. In addition, our flagship hospital, Aster Medcity in Kochi, is undergoing a substantial upgrade. By FY27, our total bed capacity in Kerala is expected to reach 3,453, marking a milestone in our journey of delivering quality healthcare and driving sustainable growth. Affordable healthcare remains a chimera for the average citizen. What is Aster doing differently on this front? To balance affordability and sustainability, we centralise complex procedures in larger hospitals, while smaller units focus on primary/secondary care. By FY27, as much as 57% of our planned bed additions will be in tier 2/3 cities, reinforcing our commitment to these regions. Technology is key to bridging gaps, with telemedicine set to grow at 20.7% annually till FY30, reaching $15.1 billion. Our digital health arm is expanding tele-ICU, teleradiology, AI-driven diagnostics, IoT monitoring, and EMR platforms to enhance accessibility, affordability, and quality care nationwide. What are the digital initiatives of the group? Some of our technology-driven, patient-friendly initiatives include the introduction of the Aster Health app that offers appointment bookings, e-pharmacy, and access to digital health records. We have come up with AI-powered diagnostic solutions, including the Carpal Tunnel Syndrome detection tool in collaboration with the Indian Institute of Science. We are also expanding the home healthcare services under Aster@Home, providing in-home consultations, diagnostics, and physiotherapy, catering to India's growing elderly and chronic care populations.
